Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber's Hereditary Optic Neuropathy (LHON)

NCT02771379 is registered in ClinicalTrials.gov with Santhera Pharmaceuticals as lead sponsor.

NCT NCT02771379
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02771379 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional Study of Clinical Experience in Patients Prescribed Raxone® for the Treatment of Leber's Hereditary Optic Neuropathy (LHON)
Lead sponsor
Santhera Pharmaceuticals
Phase
Observational
Overall status
Completed
Start date
September 30, 2016
Completion date
April 16, 2021
Enrollment
229 (actual)
Sites
26

Conditions

As the registry lists them; a condition with its own page is linked.

leber's hereditary optic neuropathy (lhon)